lidocaine has been researched along with losartan potassium in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Coulthard, MG; Hardy, SP; Hughes, C; Matthews, JN; Morris, KP | 1 |
| Allen, S; Alon, US; Harris, DJ; Kaplan, RA; Rameriz, Z; Warady, BA | 1 |
| Allen, S; Alon, US; Kaplan, RA; Warady, BA | 1 |
| Coulthard, MG; Cumming, MN; Plant, ND; Sharkey, IM; Sharp, J | 1 |
| Baudon, JJ; Ducrocq, S; Gold, F; Lebas, F; Mochel, F; Mucignat, V | 1 |
4 trial(s) available for lidocaine and losartan potassium
| Article | Year |
|---|---|
Pain after subcutaneous injection of recombinant human erythropoietin: does Emla cream help?
Topics: Adult; Aged; Anemia; Anesthetics, Local; Double-Blind Method; Drug Combinations; Erythropoietin; Female; Humans; Injections, Subcutaneous; Kidney Failure, Chronic; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Middle Aged; Ointments; Pain; Pain Measurement; Prilocaine; Recombinant Proteins; Renal Dialysis | 1994 |
Lidocaine for the alleviation of pain associated with subcutaneous erythropoietin injection.
Topics: Adolescent; Child; Child, Preschool; Cross-Over Studies; Erythropoietin; Female; Hematocrit; Humans; Injections, Subcutaneous; Kidney Failure, Chronic; Lidocaine; Male; Pain; Peritoneal Dialysis; Recombinant Proteins | 1994 |
Subcutaneous erythropoietin alpha (Eprex) is more painful than erythropoietin beta (Recormon)
Topics: Adult; Anesthetics, Local; Child; Drug Compounding; Erythropoietin; Female; Humans; Injections, Subcutaneous; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Pain; Prilocaine; Recombinant Proteins; Renal Insufficiency | 1998 |
[Analgesic effects of Emla cream and saccharose solution for subcutaneous injections in preterm newborns: a prospective study of 265 injections].
Topics: Administration, Cutaneous; Administration, Oral; Analysis of Variance; Anesthetics, Combined; Anesthetics, Local; Combined Modality Therapy; Drug Therapy, Combination; Erythropoietin; Facial Expression; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Injections, Subcutaneous; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Pacifiers; Pain; Pain Measurement; Prilocaine; Prospective Studies; Solutions; Sucking Behavior; Sucrose; Treatment Outcome | 2004 |
2 other study(ies) available for lidocaine and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of lidocaine on the hematopoietic properties of recombinant human erythropoietin in the uremic rat.
Topics: Animals; Creatinine; Drug Combinations; Erythropoiesis; Erythropoietin; Lidocaine; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Uremia | 1994 |